Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12004083 | 0.78 | TP53 (0.39) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL3864202 | 0.78 | CYP3A4 (0.50) | ALDH1A1TSHRTDP1CA1CA2 | |
| SCHEMBL217938 | 0.73 | ALDH1A1 (0.57) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL353448 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL16960592 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL18863397 | 0.72 | TP53 (0.39) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL2788648 | 0.72 | ALDH1A1 (0.50) | ALDH1A1TSHRTDP1TP53 | |
| SCHEMBL7814448 | 0.71 | APEX1 (0.45) | APEX1ALDH1A1CA1CA2CA4 | |
| SCHEMBL11041539 | 0.71 | APEX1 (0.45) | APEX1TDP1CA1CA2CA4 | |
| SCHEMBL19655038 | 0.69 | TRPA1 (0.38) | TSHRTDP1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116041610-B | Polymer enzyme activator and preparation method thereof | 苏州麦斯达尔医疗科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-116041610-A | Polymer enzyme activator and preparation method thereof | 苏州麦斯达尔医疗科技有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-116041610-B | Polymer enzyme activator and preparation method thereof | 苏州麦斯达尔医疗科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-116041610-A | Polymer enzyme activator and preparation method thereof | 苏州麦斯达尔医疗科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | APEX1 1362/4885ALDH1A1 1585/4885TSHR 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.